1994
DOI: 10.1093/infdis/170.5.1331
|View full text |Cite
|
Sign up to set email alerts
|

In Vivo Activity Of Interferon-  In Combination With Amphotericin B In The Treatment Of Experimental Cryptococcosis

Abstract: The effect of recombinant interferon-gamma (rIFN-gamma) on Cryptococcus neoformans infection was investigated in vivo. BALB/c mice were injected intravenously with 2 x 10(6) C. neoformans. rIFN-gamma alone (10 micrograms intraperitoneally 18 h before, at, 24 h after infection) significantly increased the survival and decreased the colony-forming unit counts in the lungs compared with untreated mice. rIFN-gamma association significantly enhanced the effect of a single dose of amphotericin B (0.25 mg/kg 24 h aft… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

2
32
0

Year Published

1996
1996
2010
2010

Publication Types

Select...
5
2
1

Relationship

0
8

Authors

Journals

citations
Cited by 57 publications
(34 citation statements)
references
References 16 publications
2
32
0
Order By: Relevance
“…The therapeutic potential of recombinant IFN-has been demonstrated in vivo as well as in vitro against chronic granulomatous disease [22], Cryptococcus neoformans [23], Toxoplasma gondii [21], Leishmania donovani [24] and Klebsiella pneumoniae [25]. IFN-is the principal cytokine for activating human macrophages, and it is produced in increased levels in Th1-type responses [13,15].…”
Section: Discussionmentioning
confidence: 99%
“…The therapeutic potential of recombinant IFN-has been demonstrated in vivo as well as in vitro against chronic granulomatous disease [22], Cryptococcus neoformans [23], Toxoplasma gondii [21], Leishmania donovani [24] and Klebsiella pneumoniae [25]. IFN-is the principal cytokine for activating human macrophages, and it is produced in increased levels in Th1-type responses [13,15].…”
Section: Discussionmentioning
confidence: 99%
“…These cytokines induce lymphocyte and phagocyte recruitment and activation of anti-cryptococcal delayed-type hypersensitivity responses, resulting in increased cryptococcal uptake and killing by effector phagocytes (1,6,12,18,26,27,32). Studies in mice and humans have shown some efficacy in using systemically administered recombinant Th1-type cytokines to stimulate anti-cryptococcal host responses and to enhance antifungal chemotherapy (5,15,19,20,22). Specifically, experimental studies with the Th1-type cytokine IFN-␥ have yielded some promising results as an adjunctive therapy to antifungal agents (19,29) and to significantly enhance the anti-phagocytic activity of macrophages against C. neoformans in vitro (6,12,26,34,40).…”
mentioning
confidence: 99%
“…Studies in mice and humans have shown some efficacy in using systemically administered recombinant Th1-type cytokines to stimulate anti-cryptococcal host responses and to enhance antifungal chemotherapy (5,15,19,20,22). Specifically, experimental studies with the Th1-type cytokine IFN-␥ have yielded some promising results as an adjunctive therapy to antifungal agents (19,29) and to significantly enhance the anti-phagocytic activity of macrophages against C. neoformans in vitro (6,12,26,34,40). Mucci et al have engineered a murine macrophage cell line to express IFN-␥ in an inducible manner, and this cell line was shown to enhance the anticryptococcal activity of microglial cells in a coculture system (33).…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…To assess glucose uptake, a-methyl glucopyranoside (AMG) uptake was tested in the absence and presence of phlorizin, a potent inhibitor of the Na þ -dependent glucose co-transporter (Rabito and Ausiello, 1980). The uptake assay was performed with a-[ 14 C]AMG (NEN, Boston, MA) as described previously (Joly et al, 1990). Radioactive counts were normalized to the protein content as determined using the Coomassie Protein Assay Reagent (Pierce, Rockford, IL).…”
Section: Virus Production and Cell Transductionmentioning
confidence: 99%